Abstract
Premalignant lesions present a particularly unique challenge in penile cancer. They can be difficult to distinguish from other benign dermatoses and have an uncertain natural history. A tendency for delayed presentation, with an all too common history of long-term self management, or unsuccessful treatment, often results in a relatively treatable premalignant lesion progressing to an invasive carcinoma, requiring more aggressive surgery, with poorer outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gregoire L, Cubilla AL, Reuter VE, et al. Preferential association of human papillomavirus with high-grade histologic variants of penile invasive squamous cell carcinoma. J Natl Cancer Inst. 1995;87:1705-1709.
Bezerra A, Lopes A, Santiago G, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91:2315-2321.
Iwasawa A, Kumamoto Y, Fujinaga K. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol. 1993;149:59-63.
Sarkar FH, Miles BJ, Plieth DH, et al. Detection of human papillomavirus in squamous neoplasm of the penis. J Urol. 1992;147:389-392.
Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211-1218.
Heideman DA, Waterboer T, Pawlita M, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol. 2007;25(29):4550-4556.
Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20(4):449-457.
Ambrosio MR, Onorati M, Rocca BJ, et al. Vulvar cancer and HPV infection: analysis of 22 cases. Pathologica. 2008;100:405-407.
McDougall JK. Immortalization. and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol. 1994;186:101-119.
Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76-79.
Dyson N, Howley PM, Münger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-937.
zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342-350.
Chaux A, Pfannl R, Lloveras B, et al. Distinctive association of p16INK4a over-expression with penile intraepithelial neoplasia (PeIN) depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature. Am J Surg Pathol. 2010: In Press
Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85(1):19-24.
Porter WM, Francis N, Hawkins D, Dinneen M, Bunker CB. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol. 2002;147(6):1159-1165.
Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen EI, zur Hausen H. Human papillomavirus type-16-related DNA in genital Bowen’s disease and in bowenoid papulosis. Int J Cancer. 1983;32(5):563-565.
Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol. 2000;115(3):396-401.
Lucia MS, MiUer GJ. Histopathology of malignant lesions of the penis. Urol Clin North Am. 1992;19:227-246.
Mikhall GR. Cancers, precancers, and pseudocancers on the male genitalia: a review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol. 1980;6:1027-1035.
Obalek S, Jablonska S, Beaudenon S, Walczak L, Orth G. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol. 1986;14(3):433-444.
von Krogh G, Horenblas SN. Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol. 2000;34:201-221.
Rosemberg SK. Sexually transmitted papillomaviral infection in men: an update. Dermatol Clin. 1991;9:317-331.
Gissmann L, De Villiers EM, Zur Hausen H. Analysis of the human genital warts (condyloma acuminate) and other genital tumor for human papillomavirus type 6 DNA. Int J Cancer. 1982;29:143-146.
Wells M, Robertson S, Lewis F. Squamous carcinoma arising in giant perianal condyloma associated with human papillomavirus types 6 and 11. Histopathology. 1988;12:319-323.
Buschke A, Lowenstein L. Uber carcinomahnliche condyloma acuminate des penis. Klin Wochenschr. 1925;4:1726-1728.
Creasman C, Haas PA, Fox TA, Balazs M. Malignant transformation of anorectal giant condyloma acuminatum (Buschke Lowenstein tumor). Dis Colon Rectum. 1989;32:481-487.
Knobling R, Failing JF. Giant condyloma acuminatum (Buschke Lowenstein tumor) of the rectum. Am J Clin Pathol. 1967;48:389-395.
Chu QD, Vereridis MP, Libbey NP, Wanebo HJ. Giant condyloma acuminatum (Buschke Lowenstein tumor) of the anorectal and perianal regions. Dis Colon Rectum. 1994;37:950-957.
Bertram P, Treutner KH, Rubben A, et al. Invasive squamous cell carcinoma in giant anorectal condyloma (Buschke Lowenstein tumor). Langenbecks Arch Chir. 1995;380:115-118.
Cubilla AL, Lloveras B, Alejo M, et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol. 2010;34(1):104-114.
Wiener JS, Effert PJ, Humphrey PA, Yu L, Liu ET, Walther PJ. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer. 1992;50(5):694-701.
Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119(5):1078-1081.
Bleeker MCG, Heideman DAM, Snijders PJF, et al. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141-150.
Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus et atrophicus and autoimmune related disease in males. Br J Dermatol. 1983;109:661-664.
Purcell KG, Spencer LV, Simpson PM, et al. HLA antigens in Lichen sclerosus et atrophicus. Arch Dermatol. 1990;126:1043-1045.
Bingham JS. Carcinoma of the penis developed in lichen sclerosus et atrophicus. Br J Vener Dis. 1978;54:350-351.
Weigand DA. Lichen sclerosus et atrophicus, multiple dysplastic keratoses and squamous-cell carcinoma of the glans penis. J Dermatol Surg Oncol. 1980;6:45-50.
Barbagli G, Palminteri E, Mirri F, Guazzoni G, Turini D, Lazzeri M. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol. 2006;175(4):1359-1363.
Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol. 1999;41:911-914.
Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000;86:459-465.
Pietrzak P, Hadway P, Corbishley CM, Watkin NA. Is the association between balanitis xerotica obliterans and penile carcinoma underestimated? BJU Int. 2006;98(1):74-76.
Powell J, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777-1783.
Perceau G, Derancourt C, Clavel C, et al. Lichen sclerosus is frequently present in penile squamous cell carcinomas but is not always associated with oncogenic human papillomavirus. Br J Dermatol. 2003;148(5):934-938.
Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, Giannotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev. 1995;4(6):491-495.
Scurry J. Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. Int J Gynecol Cancer. 1999;9:89-97.
Algaba F, Horenblas S, Pizzocaro G, Solsona E, Windahl T. European Association of Urology. EAU guidelines on penile cancer. Eur Urol. 2002;42:199-203.
Bunker CB. Male Genital Skin Disease. London: Elsevier Saunders; 2004.
Lowe FC, McCullough AR. Cutaneous horns of the penis: an approach to management. J Am Acad Dermatol. 1985;13:369-373.
Hemandez-Graulau JM, Fiore A, Cea P, et al. Multiple penile horns: case report and review. J Urol. 1988;139:1055-1056.
Solivan GA, Smith KJ, James WD. Cutaneous horn of the penis: its association with squamous cell carcinoma and HPV-16 infection. J Am Acad Dermatol. 1990;23:969-972.
Yeager JK, Findlay RF, Mcaleer IM. Penile verrucous carcinoma. Arch Dermatol. 1990;126(9):1208-1210.
Mikhail GR. Cancers, precancers, and pseudocancers in the male genitalia. a review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol. 1980;6:1027-1035.
Schellhammer PF, Jordan GH, Robey EL, et al. Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum. Urol Clin North Am. 1992;19:131-142.
Lever WF, Schaumburg-Lever G. Histopathology of the Skin. 5th ed. Philadelphia: JB Lippincott; 1990.
Bargman H. Pseudoepitheliomatous, keratotic, and micaceous balanitis. Cutis. 1985;35:77-79.
Bashir SJ, Grant JW, Burrows NP. Pseudoepitheliomatous, keratotic and micaceous balanitis after penile squamous cell carcinoma. Clin Exp Dermatol. 2010;35(7):749-751.
Gray MR, Ansell ID. Pseudo-epitheliomatous hyperkeratotic and micaceous balanitis: evidence for regarding it as pre-malignant. Br J Urol. 1990;66(1):103-104.
Beljaards RC, van Dijk E, Hausman R. Is pseudoepitheliomatous micaceous and keratotic balanitis synonymous with verrucous carcinoma? Br J Dermatol. 1987;117:641-646.
Bart RS, Kopf AW. On a dilemma of penile horns: pseudoepitheliomatous, hyperkeratotic and micaceous balanitis? J Dermatol Surg Oncol. 1977;3(6):580-582.
Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 2004;94(9):1253-1257.
Porter WM, Francis N, Hawkins D, et al. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol. 2002;147(6):1159-1165.
Goette DK, Elgart M, DeVillez RL. Erythroplasia of Queyrat treatment with topically applied 5-Fluorouracil. JAMA. 1975;232(9):934-937.
Micali G, Nasca MR, Tedeschi A. Topical treatment of intraepithelial penile carcinoma with imiquimod. Clin Exp Dermatol. 2003;28(Suppl 1):4-6.
Slade HB, Owens ML, Tomai MA, Miller RL. Imiquimod 5% cream (Aldara). Expert Opin Investig Drugs. 1998;7:437-449.
Suzuki H, Wang B, Shivji GM, et al. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol. 2000;114:135-141.
Pasieczny TA. The treatment of balanitis xerotica obliterans with testosterone propionate ointment. Acta Derm Venereol. 1977;57(3):275-277.
Skierlo P, Heise H. Testosterone propionate ointment—a therapeutic trial in lichen sclerosus et atrophicus [Article in German]. Hautarzt. 1987;38(5):295-297.
Ayhan A, Guven S, Guvendag Guven ES, Sakinci M, Gultekin M, Kucukali T. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynaecol Obstet. 2007;96(2):117-121.
Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology. 1998;52:559-565.
van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol. 2001;166(5):1670-1671.
Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term follow up. J Urol. 2003;169(6):2118-2121.
Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ. Longterm follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759-762.
Hansen JP, Drake AL, Walling HW. Bowen’s Disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg. 2008;34(7):878-883.
Paoli J, Ternesten Bratel A, Löwhagen GB, Stenquist B, Forslund O, Wennberg AM. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm Venereol. 2006;86(5):418-421.
Hegarty PK, Shabbir M, Hughes B, et al. Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience. World J Urol. 2009;27:179-187.
Hadway P, Corbishley CM, Watkin NA. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int. 2006;98(3):532-536.
Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin North Am. 1992;19(2):291-304.
Shindel AW, Mann MW, Lev RY, et al. Mohs micrographic surgery for penile cancer: management and long-term followup. J Urol. 2007;178(5):1980-1985.
Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161-168.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Shabbir, M., Watkin, N.A., Muneer, A. (2011). Premalignant Lesions of the Penis. In: Muneer, A., Arya, M., Horenblas, S. (eds) Textbook of Penile Cancer. Springer, London. https://doi.org/10.1007/978-1-84882-879-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-84882-879-7_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-878-0
Online ISBN: 978-1-84882-879-7
eBook Packages: MedicineMedicine (R0)